Recent Press Releases

GSK receives offer for its thrombosis brands and related manufacturing site

GSK receives offer for its thrombosis brands and related manufacturing site Issued: Tuesday 18 June 2013, London UK GlaxoSmithKline (LSE: GSK) has today received an offer for its thrombosis brands...

EISAI TO MAKE NEW INVESTMENT IN EXPANSION OF GLOBAL PACKAGING FACILITY AT HATFIELD PRODUCTION PLANT IN U.K.

EISAI TO MAKE NEW INVESTMENT IN EXPANSION OF GLOBAL PACKAGING FACILITY AT HATFIELD PRODUCTION PLANT IN U.K. Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai")...

CATALENT PHARMA SOLUTIONS BREAKS GROUND ON A MAJOR EXPANSION OF ITS WINCHESTER, KENTUCKY CONTROLLED RELEASE MANUFACTURING FACILITY

CATALENT PHARMA SOLUTIONS BREAKS GROUND ON A MAJOR EXPANSION OF ITS WINCHESTER, KENTUCKY CONTROLLED RELEASE MANUFACTURING FACILITY Investment of nearly $35 million will create more than 90...

ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS

ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial...

Rexam Healthcare expands its manufacturing capabilities in Normandy, France

Rexam Healthcare expands its manufacturing capabilities in Normandy, France 5 June, 2013 Rexam Healthcare, a subsidiary of the UK group Rexam, has announced the expansion of manufacturing...

Boehringer Ingelheim pioneers biopharmaceuticals move to China

Boehringer Ingelheim pioneers biopharmaceuticals move to China • First international company using cell culture technology to produce biopharmaceuticals in China •...

Celerion Expands Belfast Facility with Containment Room to Enable Live Biologics and Vaccine Studies

Celerion Expands Belfast Facility with Containment Room to Enable Live Biologics and Vaccine Studies (Lincoln, NE; June 5, 2013) – Celerion, announces the addition of a Containment Room at...

Impax Laboratories Inc. - Impax Laboratories Announces Reduction in Workforce

Impax Laboratories Inc. - Impax Laboratories Announces Reduction in Workforce HAYWARD, Calif.-- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced a reduction in its workforce as a part of the...

Sandoz responds to FDA warning letter

Sandoz responds to FDA warning letter Holzkirchen, June 04, 2013 Sandoz and Novartis announced today that the U.S. Food and Drug Administration (FDA) issued a Warning Letter concerning the...

Cancer Drug Shortages Hit 83 Percent of U.S. Oncologists

Cancer Drug Shortages Hit 83 Percent of U.S. Oncologists Chemotherapy Shortages Delay Treatments, Force Rationing and Expensive Drug Substitutions, and Slow Enrollment in Clinical Trials, Study from...

UPS Officially Opens Hangzhou Healthcare Facility As Part Of Global Expansion

UPS Officially Opens Hangzhou Healthcare Facility As Part Of Global Expansion Brings Best Practices, Industry-leading Technologies, Innovative Solutions and Expertise to Customers in China Hangzhou,...

CorePharma Addresses Violations in FDA Warning Letter

CorePharma Addresses Violations in FDA Warning Letter Receives Closeout Letter from FDA MIDDLESEX, N.J., May 28, 2013 -- CorePharma LLC ("CorePharma"), a developer, manufacturer, and...

CPhI announces founding members of expert industry panel

CPhI announces founding members of expert industry panel Panel to leverage their collective expertise to create monthly and annual reports to explore future contingencies effecting the global...

UPM Pharmaceuticals® Purchases Pfizer Commercial Manufacturing site in Bristol, TN

UPM Pharmaceuticals® Purchases Pfizer Commercial Manufacturing site in Bristol, TN BALTIMORE, May 29, 2013 /PRNewswire/ -- UPM Pharmaceuticals, a Baltimore, Maryland-based drug development and...

Fresenius Kabi USA Initiates Voluntary Recall of Single Lot of Magnesium Sulfate

Fresenius Kabi USA Initiates Voluntary Recall of Single Lot of Magnesium Sulfate LAKE ZURICH, Ill.--Fresenius Kabi USA announced today it has initiated a voluntary recall of one lot – Lot...

Unither will acquire UCB pharmaceutical plant in Rochester, New york, US.

Unither will acquire UCB pharmaceutical plant in Rochester, New york, US. The plant employs 250 people and mainly manufacturers liquid pharmaceutical products. This acquisition is a part of...

UCB : to secure long-term partnership with UNITHER Pharmaceuticals for its Rochester manufacturing facility

UCB : to secure long-term partnership with UNITHER Pharmaceuticals for its Rochester manufacturing facility Brussels (Belgium), May 29, 2013 - 7 a.m. - UCB has agreed with UNITHER...

Health Canada: Three Companies Voluntarily Recalling All Lots of Their Antipsychotic Medication Due to Possible Contamination Issues

Health Canada: Three Companies Voluntarily Recalling All Lots of Their Antipsychotic Medication Due to Possible Contamination Issues OTTAWA, ONTARIO- May 18, 2013) - The issue: In consultation with...

TWi Pharmaceuticals' Manufacturing Site for the Generic Version of Lidoderm(R) (Lidocane 5% patch) Passes US FDA cGMP Audit and Pre-Approval Inspection

TWi Pharmaceuticals' Manufacturing Site for the Generic Version of Lidoderm(R) (Lidocane 5% patch) Passes US FDA cGMP Audit and Pre-Approval Inspection TAIPEI, Taiwan, May 29, 2013...

Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole

Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole LAVAL, Quebec, May 28, 2013 -- Valeant Pharmaceuticals International, Inc. (VRX) (TSX: VRX) today...